These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37321897)

  • 21. Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies.
    Palache A
    Vaccine; 2011 Nov; 29(51):9459-66. PubMed ID: 22024174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 2020 immunization programme landscape: Piloting an assessment metric to evaluate the maturity of national immunization programmes across the life course.
    Goldin S; Moen A; Moss WJ; Nuzzo J
    Vaccine; 2024 Jan; ():. PubMed ID: 38212202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Kraigsley AM; Moore KA; Bolster A; Peters M; Richardson D; Arpey M; Sonnenberger M; McCarron M; Lambach P; Maltezou HC; Bresee JS
    Vaccine; 2021 Jun; 39(25):3419-3427. PubMed ID: 33992439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination policies for health-care workers in acute health-care facilities in Europe.
    Maltezou HC; Wicker S; Borg M; Heininger U; Puro V; Theodoridou M; Poland GA
    Vaccine; 2011 Nov; 29(51):9557-62. PubMed ID: 21964058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of healthcare personnel in Europe: Update to current policies.
    Maltezou HC; Botelho-Nevers E; Brantsæter AB; Carlsson RM; Heininger U; Hübschen JM; Josefsdottir KS; Kassianos G; Kyncl J; Ledda C; Medić S; Nitsch-Osuch A; de Lejarazu RO; Theodoridou M; Van Damme P; van Essen GA; Wicker S; Wiedermann U; Poland GA;
    Vaccine; 2019 Dec; 37(52):7576-7584. PubMed ID: 31623916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009.
    Mereckiene J; Cotter S; D'Ancona F; Giambi C; Nicoll A; Levy-Bruhl D; Lopalco PL; Weber JT; Johansen K; Dematte L; Salmaso S; Stefanoff P; Greco D; Dorleans F; Polkowska A; O'Flanagan D;
    Euro Surveill; 2010 Nov; 15(44):. PubMed ID: 21087586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring progress of maternal and neonatal immunization in Latin America and the Caribbean.
    Velandia-González M; Vilajeliu A; Contreras M; Trumbo SP; Pacis C; Ropero AM; Ruiz-Matus C
    Vaccine; 2021 Jul; 39 Suppl 2():B55-B63. PubMed ID: 33715899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine stockouts around the world: Are essential vaccines always available when needed?
    Lydon P; Schreiber B; Gasca A; Dumolard L; Urfer D; Senouci K
    Vaccine; 2017 Apr; 35(17):2121-2126. PubMed ID: 28364919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination policies of immigrants in the EU/EEA Member States-the measles immunization example.
    Bica MA; Clemens R
    Eur J Public Health; 2018 Jun; 28(3):439-444. PubMed ID: 29136141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.
    Cherian T; Morales KF; Mantel C; Lambach P;
    Vaccine; 2019 Oct; 37(43):6255-6261. PubMed ID: 31500965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in vaccine investment in middle income countries.
    Onishchenko K; Hill S; Wasserman M; Jones C; Moffatt M; Ruff L; Pugh SJ
    Hum Vaccin Immunother; 2019; 15(10):2378-2385. PubMed ID: 30843757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.
    Bell S; Blanchard L; Walls H; Mounier-Jack S; Howard N
    Health Policy Plan; 2019 May; 34(4):271-281. PubMed ID: 31074778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Bresee JS; Lafond KE; McCarron M; Azziz-Baumgartner E; Chu SY; Ebama M; Hinman AR; Xeuatvongsa A; Bino S; Richardson D; Porter RM; Moen A; McKinlay M;
    Vaccine; 2019 Aug; 37(35):5089-5095. PubMed ID: 31288998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers for vaccination of healthcare workers.
    Eltvedt AK; Poulsen A; Winther TN; Von Linstow ML
    Hum Vaccin Immunother; 2021 Sep; 17(9):3073-3076. PubMed ID: 33905303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving measles status and immunization policy development in six European countries.
    Vojtek I; Larson H; Plotkin S; Van Damme P
    Hum Vaccin Immunother; 2022 Dec; 18(1):2031776. PubMed ID: 35180372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
    Kahn AL; Steffen CA; Henaff L; MacDonald NE; Morgan C; Faden R; Olayinka F; Desai S
    Vaccine; 2023 Jan; 41(3):676-683. PubMed ID: 36494252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of health worker vaccination programs in low, middle and upper middle-income countries.
    Gaviola GC; McCarville M; Shendale S; Goodman T; Lomazzi M; Desai S
    Public Health Pract (Oxf); 2023 Dec; 6():100415. PubMed ID: 37547811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.